Our Featured Research Page lists cancer prevention, treatment and quality of life studies enrolling people with or at high risk for hereditary cancers. You can do a quick search to filter our featured studies by cancer type, study type or key word, or a more in-depth search through clinicaltrials.gov.
Search Results: Prevention, Detection & Risk + Colorectal Cancer (6 results)
Prevention
Prevention study for people with Lynch syndrome
Cancer Prevention Vaccine (Nous-209) for People with Lynch Syndrome
This study is testing a vaccine, known as the Nous-209 vaccine, which is intended to decrease the chances that people with Lynch syndrome will develop polyps that can turn into cancer.
Prevention
Prevention study for people with an APC mutation and FAP who have had colectomy surgery
Testing the Safety And Action of the Investigational Drug REC-4881 in People With Familial Adenomatous Polyposis (FAP) (TUPELO Study)
This study is looking at how safe and effective the research drug REC-4881 is for treating polyps in people with Familial Adenomatous Polyposis (FAP). Participants will receive the oral drug REC-4881. A participant's dose will depend on when they join the study.
Prevention
People with Lynch Syndrome at risk for colon cancer
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Precancerous Polyps in Lynch Syndrome Patients, CORAL Study
This study will colect blood and stool samples to detect colorectal cancer or precancerous polyps in people with Lynch syndrome.
Prevention
Diet and weight loss study for people who are overweight and at increased risk of colorectal cancer
My Best GI Eating Study
This study will test three different diets in people who are overweight and who have an increased risk of colorectal cancer. The study will look at whether these diets improve eating and possibly lead to weight loss.
Prevention
Prevention study for people with Lynch syndrome
A Study Comparing Two Anti-inflammatory Medications Naproxen or Aspirin for Cancer Prevention in Lynch Syndrome
The trial is enrolling people with Lynch syndrome. On average, the length of this study will last one year from the start of enrollment to completion. The study will measure the effect of naproxen or aspirin on the immune cells in the gastrointestinal tract of people with Lynch syndrome. The trial will also evaluate any symptoms from the medications and any other changes of the colon and rectum.
Prevention
People with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome who have relatives who have not been tested
IGNITE-TX - Identifying Individuals for Genetic Testing for Familial Cancer
The IGNITE-TX study is all about helping people with a genetic mutation in BRCA1, BRCA2 or Lynch syndrome talk to their family members about their risk for cancer and find the best way to get family members tested.
Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Colorectal Cancer
39 results
Research Search Tool Sponsored By:
